Orchard Therapeutics

Acquired

Orchard Therapeutics is a biotech company in London, United Kingdom, founded in 2015. It has raised $327.0M across 4 rounds, most recently a $34.0M Extension Round in June 2023.

Homepage

Headquarters
London
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$327.0M
Last Round
$34.0M Extension RoundJun 2023
Rounds
4
Type
Public
Acquisition Date
Jan 2024

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 2 investors for this company. The full record is or through the API.

About

Founded in 2015, Orchard Therapeutics is a London-based gene therapy company and a Kyowa Kirin subsidiary since 2024, focused on ex vivo autologous hematopoietic stem cell (HSC) gene therapies for severe rare genetic diseases. The company's lead product Lenmeldy (atidarsagene autotemcel) received FDA approval for metachromatic leukodystrophy and is also approved in Europe as Libmeldy. Orchard has approximately 193 employees.

Summary

It lists 51–200 employees. It has raised $327.0M in total across 4 rounds, most recently a $34.0M Extension Round in Jun 2023. Investors include F-Prime Capital and RA Capital Management.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionAcquisition by Kyowa KirinJan 2024

Sign up to see all 6 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Orchard Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/orchard-therapeutics"><img src="https://indexed.vc/api/badge/company/orchard-therapeutics" alt="Orchard Therapeutics on Indexed.vc" width="260" height="76" /></a>